186 related articles for article (PubMed ID: 37239075)
1. Association of
Duncan A; Nousome D; Ricks R; Kuo HC; Ravindranath L; Dobi A; Cullen J; Srivastava S; Chesnut GT; Petrovics G; Kohaar I
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239075
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil.
Pinto GR; Yoshioka FK; Silva RL; Clara CA; Santos MJ; Almeida JR; Burbano RR; Rey JA; Casartelli C
Genet Mol Res; 2008 Feb; 7(1):207-16. PubMed ID: 18393224
[TBL] [Abstract][Full Text] [Related]
3. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
[TBL] [Abstract][Full Text] [Related]
4. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Sinilnikova OM; Antoniou AC; Simard J; Healey S; Léoné M; Sinnett D; Spurdle AB; Beesley J; Chen X; ; Greene MH; Loud JT; Lejbkowicz F; Rennert G; Dishon S; Andrulis IL; ; Domchek SM; Nathanson KL; Manoukian S; Radice P; Konstantopoulou I; Blanco I; Laborde AL; Durán M; Osorio A; Benitez J; Hamann U; Hogervorst FB; van Os TA; Gille HJ; ; Peock S; Cook M; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Brewer C; ; Hughes DJ; Coupier I; Giraud S; Coulet F; Colas C; Soubrier F; Rouleau E; Bièche I; Lidereau R; Demange L; Nogues C; Lynch HT; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Sutter C; Deissler H; Schaefer D; Froster UG; ; Aittomäki K; Nevanlinna H; McGuffog L; Easton DF; Chenevix-Trench G; Stoppa-Lyonnet D;
Br J Cancer; 2009 Oct; 101(8):1456-60. PubMed ID: 19707196
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma.
Elsaid A; Zahran R; Elshazli R; El-Sayed A; Abou Samra M; El-Tarapely F; Abdel-Malak C
Arch Physiol Biochem; 2019 Jul; 125(3):255-262. PubMed ID: 29560751
[TBL] [Abstract][Full Text] [Related]
6. A functionally significant SNP in TP53 and breast cancer risk in African-American women.
Murphy ME; Liu S; Yao S; Huo D; Liu Q; Dolfi SC; Hirshfield KM; Hong CC; Hu Q; Olshan AF; Ogundiran TO; Adebamowo C; Domchek SM; Nathanson KL; Nemesure B; Ambs S; Blot WJ; Feng Y; John EM; Bernstein L; Zheng W; Hu JJ; Ziegler RG; Nyante S; Ingles SA; Press MF; Deming SL; Rodriguez-Gil JL; Haiman CA; Olopade OI; Lunetta KL; Palmer JR; Ambrosone CB
NPJ Breast Cancer; 2017; 3():5. PubMed ID: 28649645
[TBL] [Abstract][Full Text] [Related]
7. Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism.
Rodríguez C; Sobrino T; Agulla J; Bobo-Jiménez V; Ramos-Araque ME; Duarte JJ; Gómez-Sánchez JC; Bolaños JP; Castillo J; Almeida Á
Cell Death Differ; 2017 Jan; 24(1):144-154. PubMed ID: 27768124
[TBL] [Abstract][Full Text] [Related]
8. TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis among Asian and Caucasian populations.
Li J; Chen Y; Mo Z; Li L
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():73-8. PubMed ID: 25889195
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.
Carvalho RM; Pinto GR; Yoshioka FK; Lima PD; Souza CR; Guimarães AC; Lamarão LM; Rey JA; Burbano RR
J Neurooncol; 2012 Oct; 110(1):49-57. PubMed ID: 22886512
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
11. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.
Onel KB; Huo D; Hastings D; Fryer-Biggs J; Crow MK; Onel K
Lupus; 2009 Jan; 18(1):61-6. PubMed ID: 19074170
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors.
Almeida LO; Custódio AC; Pinto GR; Santos MJ; Almeida JR; Clara CA; Rey JA; Casartelli C
Genet Mol Res; 2009 Jan; 8(1):8-18. PubMed ID: 19224462
[TBL] [Abstract][Full Text] [Related]
13. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
14. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
15. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
[TBL] [Abstract][Full Text] [Related]
16. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer.
Oh J; Kim JW; Lee BE; Jang MJ; Chong SY; Park PW; Hwang SG; Oh D; Kim NK
Oncol Rep; 2014 Feb; 31(2):995-1002. PubMed ID: 24337371
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis.
Pineda S; Milne RL; Calle ML; Rothman N; López de Maturana E; Herranz J; Kogevinas M; Chanock SJ; Tardón A; Márquez M; Guey LT; García-Closas M; Lloreta J; Baum E; González-Neira A; Carrato A; Navarro A; Silverman DT; Real FX; Malats N
PLoS One; 2014; 9(5):e89952. PubMed ID: 24818791
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Liu ZH; Bao ED
Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
[TBL] [Abstract][Full Text] [Related]
20. Association between
Fu W; Zhuo ZJ; Jia W; Zhu J; Zhu SB; Lin ZF; Wang FH; Xia H; He J; Liu GC
Onco Targets Ther; 2017; 10():1149-1154. PubMed ID: 28260929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
